---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-006742"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2026-08-27T12:30:16+00:00"
generated_at: "2026-08-27T12:35:23.764824+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Valion Bio announces 1-for-25 reverse stock split to regain Nasdaq compliance

## Summary
- 1-for-25 reverse stock split effective Aug 31, 2026; trading symbol VBIO unchanged, new CUSIP 918942202.
- Split aims to regain Nasdaq $1.00 minimum bid price compliance; prior notice from Nasdaq on Mar 19, 2026, deadline Sep 15, 2026.
- Stockholders approved split at special meeting Aug 14, 2026; fractional shares rounded up, no cash paid.
- Proportionate adjustments to preferred stock, warrants, options, and 2021 equity incentive plan shares.
- Transfer agent Odyssey acts as exchange agent; no action needed for book-entry or broker-held shares.

## SEC filing metadata
- accession: 0001683168-26-006742
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2026-08-27T12:30:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000168316826006742/0001683168-26-006742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000168316826006742/valion_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-006742
- JSON: https://secwatch.observer/filing/0001683168-26-006742.json
- Plain text: https://secwatch.observer/filing/0001683168-26-006742.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.